Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIH subunit 1 (GTF2H1) is a core component of the TFIIH complex, which is essential for both RNA polymerase II-mediated transcription initiation and nucleotide excision repair of damaged DNA. It plays a key role in opening DNA at promoters to allow transcription initiation and participates in the DNA repair process by facilitating the excision of damaged DNA fragments and their subsequent replacement. GTF2H1 also enables interactions with nuclear receptors and other transcriptional regulators, with disruption of its function linked to disease processes, particularly those related to DNA repair deficiency and transcriptional dysregulation.
Inhibition of DNA repair (sensitizes cells to DNA-damaging agents)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIH subunit 1 (GTF2H1).